Evidence map›Paper›PMID 28531095›Full record

ArticleMolecules (Basel, Switzerland)2017

Synthesis of 1,2,3-Triazolo[4,5-h]quinolone Derivatives with Novel Anti-Microbial Properties against Metronidazole Resistant Helicobacter pylori.

Mohammad Abu-Sini, Amal Mayyas, Nehaya Al-Karablieh, Rula Darwish, Yusuf Al-Hiari, Talal Aburjai, Shereen Arabiyat, Luay Abu-Qatouseh

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. NovelVeterinary world · 2021
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Mohammad Abu-SiniFaculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan. mohammad.abusini@zuj.edu.jo.
Amal MayyasFaculty of Health Sciences, American University of Madaba, Madaba 11821, Jordan. a.mayyas@aum.edu.jo.
Nehaya Al-KarabliehHamdi Mango Center for Scientific Research, University of Jordan, Amman 11914, Jordan. n.alkarablieh@ju.edu.jo.
Rula DarwishFaculty of Pharmacy, University of Jordan, Amman 11914, Jordan. rulad@ju.edu.jo.
Yusuf Al-HiariFaculty of Pharmacy, University of Jordan, Amman 11914, Jordan. hiary@ju.edu.jo.
Talal AburjaiFaculty of Pharmacy, University of Jordan, Amman 11914, Jordan. aburjai@ju.edu.jo.
Shereen ArabiyatSalt College, Al-Balqa Applied University, As-Salt 19117, Jordan. Shereen@bau.edu.jo.
Luay Abu-QatousehFaculty of Pharmacy, University of Petra, Amman 11914, Jordan. labuqatouseh@uop.edu.jo.
University of Jordan · JOAl-Balqa Applied University · JOAl-Zaytoonah University of Jordan · JOAmerican University of Madaba · JOPetra University · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Infective AgentsDrug Resistance, BacterialDrug SynergismDrug Therapy, CombinationFluoroquinolonesHelicobacter pyloriMetronidazoleMicrobial Sensitivity TestsStructure-Activity RelationshipTriazolesAnti-Infective AgentsFluoroquinolonesMetronidazoleTriazolesH. pylorisynergismtriazoloquinolone derivatives

Identifiers

PMID28531095
PMCPMC6154552
OpenAlexW2615731103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.